Fabio Salvatore Macaluso (Fabio S Macaluso, F S Macaluso)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

Alimentary pharmacology & therapeutics

Journal of Crohn's & colitis

Journal of gastroenterology and hepatology

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, David Laharie, Alessandro Armuzzi, Flavio Andrea Caprioli, Francisco Javier García-Alonso, Julien Kirchgesner, Fabio Salvatore Macaluso, Fernando Magro, Subrata Ghosh, null null
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus. Journal of Crohn's & colitis 18 (8) (2024)
Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, David Laharie, Alessandro Armuzzi, Flavio Andrea Caprioli, Francisco Javier García-Alonso, Julien Kirchgesner, Fabio Salvatore Macaluso, Fernando Magro, Subrata Ghosh, null null
Pragmatic trial design to compare real-world effectiveness of different treatments for inflammatory bowel diseases: the PRACTICE-IBD European consensus. Journal of Crohn's & colitis (2024)
Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, David Laharie, Alessandro Armuzzi, Flavio Andrea Caprioli, Francisco Javier García-Alonso, Julien Kirchgesner, Fabio Salvatore Macaluso, Fernando Magro, Subrata Ghosh, null null
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus. Journal of Crohn's & colitis 18 (8) (2024)
Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, David Laharie, Alessandro Armuzzi, Flavio Andrea Caprioli, Francisco Javier García-Alonso, Julien Kirchgesner, Fabio Salvatore Macaluso, Fernando Magro, Subrata Ghosh, null null
Pragmatic trial design to compare real-world effectiveness of different treatments for inflammatory bowel diseases: the PRACTICE-IBD European consensus. Journal of Crohn's & colitis (2024)
Fabio Salvatore Macaluso, Ambrogio Orlando
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Alimentary pharmacology & therapeutics 57 (11) (2023)
Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini, Simone Saibeni, Cristina Bezzio, Fabiana Castiglione, Olga Maria Nardone, Rocco Spagnuolo, Massimo Claudio Fantini, Gaia Riguccio, Simone Conforti, Flavio Caprioli, Chiara Viganò, Carla Felice, Gionata Fiorino, Carmen Correale, Giorgia Bodini, Monica Milla, Giulia Scardino, Marta Vernero, Federico Desideri, Fabrizio Bossa, Maria Guerra, Marco Ventimiglia, Angelo Casà, Giuseppe Rizzo, Ambrogio Orlando, null null
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study. Inflammatory bowel diseases (2023)
Fabio Salvatore Macaluso, Marco Ventimiglia, Ambrogio Orlando
Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies. Journal of Crohn's & colitis (2023)
Fabio Salvatore Macaluso, Ambrogio Orlando
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Alimentary pharmacology & therapeutics 57 (11) (2023)
Fabio Salvatore Macaluso, Mauro Grova, Filippo Mocciaro, Roberto Di Mitri, Antonino Carlo Privitera, Maria Emanuela Distefano, Alessandro Vitello, Salvatore Camilleri, Concetta Ferracane, Dario Pluchino, Nunzio Belluardo, Emiliano Giangreco, Walter Fries, Anna Viola, Maria Cappello, Livia D'Amato, Carmelo Bertolami, Marco Ventimiglia, Sara Renna, Angelo Casà, Elvira D'Antonio, Simona De Vivo, Ambrogio Orlando, null null
Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease. Journal of gastroenterology and hepatology (2023)
Fabio Salvatore Macaluso, Alessandra Giuliano, Walter Fries, Anna Viola, Alfredo Abbruzzese, Maria Cappello, Enrica Giuffrida, Lucio Carrozza, Antonino Carlo Privitera, Antonio Magnano, Concetta Ferracane, Giuseppe Scalisi, Maria Giovanna Minissale, Emiliano Giangreco, Serena Garufi, Carmelo Bertolami, Ugo Cucinotta, Francesco Graziano, Angelo Casà, Sara Renna, Giulia Teresi, Giulia Rizzuto, Mariella Mannino, Marcello Maida, Ambrogio Orlando
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19. Inflammatory bowel diseases (2022)
Federica Crispino, Mauro Grova, Erica Maria Bruno, Noemi Monachino, Giuseppe Rizzo, Angelo Casà, Sara Renna, Fabio Salvatore Macaluso, Ambrogio Orlando
Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets. Drugs 82 (11) (2022)
Fabio Salvatore Macaluso, Ambrogio Orlando
Letter: propensity score-handle with care. Alimentary pharmacology & therapeutics 53 (2) (2021)
Anna Viola, Marco Muscianisi, Fabio Salvatore Macaluso, Marco Ventimiglia, Maria Cappello, Antonino C Privitera, Antonio Magnano, Dario Pluchino, Giovanni Magrì, Concetta Ferracane, Filippo Mocciaro, Serena Garufi, Enrica Giuffrida, Giuseppe Costantino, Gabriele Fiocco, Mauro Grova, Laura Guida, Angela Alibrandi, Ambrogio Orlando, Walter Fries, null null
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases. JGH open : an open access journal of gastroenterology and hepatology 5 (3) (2021)
Fabio Salvatore Macaluso, Marcello Maida, Mauro Grova, Federica Crispino, Giulia Teresi, Adele Orlando, Ambrogio Orlando
Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience. Therapeutic advances in gastroenterology 14 (2021)
Fabio Salvatore Macaluso, Maria Cappello, Anita Busacca, Walter Fries, Anna Viola, Giuseppe Costantino, Antonio Magnano, Elisa Vinci, Concetta Ferracane, Antonino Carlo Privitera, Giovita Piccillo, Nunzio Belluardo, Emiliano Giangreco, Claudio Romano, Michele Citrano, Francesco Graziano, Serena Garufi, Carmelo Bertolami, Marco Ventimiglia, Barbara Scrivo, Giulia Teresi, Sara Renna, Giulia Rizzuto, Angelo Casà, Ambrogio Orlando, null null
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. Journal of gastroenterology and hepatology 36 (11) (2021)
Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Anna Viola, Aldo Sitibondo, Maria Cappello, Barbara Scrivo, Anita Busacca, Antonino Carlo Privitera, Salvatore Camilleri, Serena Garufi, Roberto Di Mitri, Filippo Mocciaro, Nunzio Belluardo, Emiliano Giangreco, Carmelo Bertolami, Sara Renna, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando, null null
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease. Journal of gastroenterology and hepatology 36 (1) (2020)
Giuseppe Maria Garbo, Sara Renna, Valentina Caputo, Elisabetta Orlando, Fabio Salvatore Macaluso, Rosalba Orlando, Maria Rita Bongiorno, Ambrogio Orlando
Letter: psoriasiform eruption during vedolizumab therapy. Alimentary pharmacology & therapeutics 50 (3) (2020)
Barbara Scrivo, Sara Renna, Angelo Casà, Noemi Monachino, Fabio Salvatore Macaluso, Ambrogio Orlando
Letter: mesalazine-a safe drug with rare serious adverse events. Alimentary pharmacology & therapeutics 51 (11) (2020)
Fabio Salvatore Macaluso, Walter Fries, Sara Renna, Anna Viola, Marco Muscianisi, Maria Cappello, Laura Guida, Sebastiano Siringo, Salvatore Camilleri, Serena Garufi, Antonino Carlo Privitera, Nunzio Belluardo, Emiliano Giangreco, Carmelo Bertolami, Roberto Vassallo, Giulia Rizzuto, Rosalba Orlando, Marco Ventimiglia, Ambrogio Orlando, null null
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study. United European gastroenterology journal 8 (9) (2020)
Fabio Salvatore Macaluso, R Orlando, Sara Renna, C Sapienza, M Ventimiglia, G Rizzuto, M Cottone, A Orlando
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab. Alimentary pharmacology & therapeutics 47 (7) (2019)
Fabio Salvatore Macaluso, Maria Cappello, Enrica Giuffrida, Walter Fries, Andrea Centritto, Antonio Carlo Privitera, Gaetano Inserra, Roberto Vassallo, Antonio Magnano, Elisa Vinci, Serena Garufi, Marco Ventimiglia, Sara Renna, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando, null null
Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2. Alimentary pharmacology & therapeutics 49 (2) (2019)
Giovanni Mazzola, Lucia Adamoli, Vincenza Calvaruso, Fabio Salvatore Macaluso, Pietro Colletti, Sergio Mazzola, Adriana Cervo, Marcello Trizzino, Francesco Di Lorenzo, Chiara Iaria, Tullio Prestileo, Ambrogio Orlando, Vito Di Marco, Antonio Cascio
Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients. Infection 47 (3) (2018)

Fabio Salvatore Macaluso.css-eqlu8i{font-size:small;padding-left:4px;} (Fabio S Macaluso, F S Macaluso)

Publication Activity (10 Years)

Top Topics

Top Venues

Fabio Salvatore Macaluso (Fabio S Macaluso, F S Macaluso)